載入...
Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
PURPOSE: The purpose of this study was to compare ramosetron (RAM), aprepitant (APR), and dexamethasone (DEX) [RAD] with palonosetron (PAL), APR, and DEX [PAD] in controlling highly-emetogenic chemotherapy (HEC)–induced nausea and vomiting. MATERIALS AND METHODS: Patients were randomly assigned (1:1...
Na minha lista:
| 發表在: | Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Korean Cancer Association
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7373869/ https://ncbi.nlm.nih.gov/pubmed/32192275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2019.713 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|